Skip to main content

Table 5 Prevalence of HPV by head and neck cancer type a

From: Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis

Cancer type

Number of patients/patient samples tested

Prevalence (%)

95% confidence interval

Low (%)

High (%)

Base of tongue

193

47.2

37.3

57.1

Hypopharyngeal

50

42.4

14.7

70.2

Laryngeal

498

40.0

34.6

45.5

Oral

1,157

26.6

19.8

33.3

Oropharyngeal

894

41.3

31.8

50.7

Pharyngeal

25

15.3

3.0

27.7

Tongue

113

25.7

3.4

47.9

Tonsillar

605

66.4

57.2

75.6

Waldeyer’s ring

113

32.9

12.7

53.1

All head and neck cancers

3,649

40.0

34.6

45.5

  1. aAggregate head and neck cancer prevalence estimates include one case of paranasal sinus cancer with unadjusted prevalence estimates of 100.0%; 95% CI: 60.3% to 139.7% (adjusted values to reflect prevalence estimates exceeding 100%: 60.3%; 95% CI: 20.6% to 100.0%).